BIOCON - Heavy downfall could be expected

Negative financial results reported could drag the stock further down the ladder. As the price has already breached the levels of 326, we could see levels of 316-309-296 on the down side.
On the buying side if the stock breaches the level of 333.35 we can keep targets of 337-350-357.

More focus would be on the selling side.